Gilead and PAHO agree to expedite lenacapavir access for HIV prevention
The collaboration enables 14 countries to access lenacapavir for PrEP outside of Gilead’s current voluntary licensing agreements.
Drug Development
Eli Lilly and QurCan sign genetic medicine deal
Cheplapharm to take over 20 medicines and three sites from Sanofi
FDA reduces monitoring time for Amgen’s Imdelltra infusions
Exegenesis Bio and Modalis sign research deal for Duchenne therapy
ABEC to expand global manufacturing network with new Wilson facility
Solstice Oncology secures $225m to drive porustobart’s development for cancer
TwoStep Therapeutics raises $62.5m in funding to advance TS-104
